Medicine guide

ABECMA

As listed in the register: ABECMA 260-500 x 10e6 CELULAS DISPERSION PARA PERFUSION

260 - 500 × 10e6 células · dispersion para perfusion

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Idecabtagén vicleucel
Made by
Bristol-Myers Squibb Pharma Eeig

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01XL07

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byBristol-Myers Squibb Pharma Eeig
Active substanceIdecabtagén vicleucel
Used inCancer treatments and immune-system medicines
Strength260 - 500 × 10e6 células
Formdispersion para perfusion
ClassificationL01XL07 · Cancer treatments and immune-system medicines
Routevía intravenosa
MarketedYes, according to the register
Orphan medicineYes — designated for a rare disease, according to the register
Additional monitoring ▼Yes — under additional monitoring (black triangle). Report suspected side effects.
DrivingThe regulator flags that this medicine can affect the ability to drive.
Name in the registerABECMA 260-500 x 10e6 CELULAS DISPERSION PARA PERFUSION
Nº Registro1211539001

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.